Notice2022-15740
Solicitation of Nominations for Appointment to the Clinical Laboratory Improvement Advisory Committee (CLIAC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 22, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the Clinical Laboratory Improvement Advisory Committee (CLIAC). CLIAC, consisting of 20 members including the Chair, represents a diverse membership across laboratory specialties, professional roles (laboratory management, technical specialists, physicians, nurses) and practice settings (academic, clinical, public health), and includes a consumer representative.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 140 (Friday, July 22, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 140 (Friday, July 22, 2022)]
[Notices]
[Pages 43859-43860]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-15740]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Clinical
Laboratory Improvement Advisory Committee (CLIAC)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the Clinical Laboratory
Improvement Advisory Committee (CLIAC). CLIAC, consisting of 20 members
including the Chair, represents a diverse membership across laboratory
specialties, professional roles (laboratory management, technical
specialists, physicians, nurses) and practice settings (academic,
clinical, public health), and includes a consumer representative.
DATES: Nominations for membership on CLIAC must be received no later
than September 30, 2022. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to <a href="/cdn-cgi/l/email-protection#185b5451595b587b7c7b367f776e"><span class="__cf_email__" data-cfemail="de9d92979f9d9ebdbabdf0b9b1a8">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Heather Stang, MS, CLIAC Management
Specialist, Deputy Chief, Quality and Safety Systems Branch, Division
of Laboratory Systems, Center for Surveillance, Epidemiology, and
Laboratory Services, Office of Public Health Scientific Services,
Centers for Disease Control and Prevention, 1600 Clifton Road NE,
Mailstop V24-3, Atlanta, Georgia 30329-4027; Telephone (404) 498-2769;
Email: <a href="/cdn-cgi/l/email-protection#c08893b4a1aea780a3a4a3eea7afb6"><span class="__cf_email__" data-cfemail="afe7fcdbcec1c8efcccbcc81c8c0d9">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Nominations are being sought for individuals
who have the expertise and qualifications necessary to contribute to
the accomplishment of the Committee's objectives. Nominees will be
selected based on expertise in the fields of microbiology (including
bacteriology, mycobacteriology, mycology, parasitology, and virology),
immunology (including histocompatibility), chemistry, hematology,
pathology (including histopathology and cytology), or genetic testing
(including cytogenetics); from representatives in the fields of medical
technology, bioinformatics, public health, and clinical practice; and
from consumer representatives. Federal employees will not be considered
for membership. Members may be invited to serve for up to four-year
terms.
The selection of members is based on candidates' qualifications to
contribute to accomplishing CLIAC objectives (<a href="https://www.cdc.gov/cliac/">https://www.cdc.gov/cliac/</a>).
The U.S. Department of Health and Human Services (HHS) policy
stipulates that committee membership be balanced in terms of points of
view represented and the Committee's function. Appointments shall be
made without discrimination on the basis of age, race, ethnicity,
gender, sexual orientation, gender identity, HIV status, disability,
and cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees, requiring the filing of
financial disclosure reports at the beginning and annually during their
terms. CDC reviews potential candidates for CLIAC membership each year
and provides a slate of nominees for consideration to the Secretary of
HHS for final selection. HHS notifies selected candidates of their
appointment near the start of the term in July or as soon as the HHS
selection process is completed. Note that the need for different
expertise varies from year to year, and a candidate who is not selected
in one year may be reconsidered in a subsequent year. Candidates should
submit the following items:
[[Page 43860]]
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address)
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
Candidates may submit a letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-15740 Filed 7-21-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 22, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.